Cloning, expression and characterization of mouse (Mus musculus) nicotinamide 5'-mononucleotide adenylyltransferase-2

Medicinal Chemistry

Volumn 7, Issue 6, 2011, Pages 718-726

  Raches, David W ^a   Xiao, Suhong ^b   Kusumanchi, Praveen ^c   Yalowitz, Joel ^b   Sanghani, Paresh ^a   Long, Eric C ^d   Antony, Aśok C ^b,c   Jayaram, Hiremagalur N ^a,c  

^a Department of Biochemistry and Molecular Biology ^*  (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Circular dichroism; MALDI TOF; Mouse NMNAT 2; NAD; Tiazofurin; Tissue expression

Indexed keywords

NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; RECOMBINANT ENZYME; RECOMBINANT NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ALPHA HELIX; ANIMAL TISSUE; ARTICLE; BETA SHEET; CIRCULAR DICHROISM; EMBRYO; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE CONTROL; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 80755161488     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340611797928262     Document Type: Article

References (45)

1. + synthesis:Structures of methanobacterium thermoautothophicum NMN adenylyltransferase complexes. J. Biol. Chem., 2001, 276, 7225-32.
2. Foster, J.W.; Moat, A.G. Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. Microbiol. Rev., 1980, 44, 83-105. (Pubitemid 10087652)
3. Berger, F.; Lu, C,; Ziegler, M. Regulation of poly (ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyltransferase-1. Proc. Nat. Acad. Sci. USA, 2007, 104, 3765-70. (Pubitemid 47181528)
4. Anderson, R.M.; Bitterman, K.J.; Wood, J.G.; Medvedik, O.; Sinclair, D.A. Yeast life-span extension by calorie restriction is independent of NAD fluctuation. Nature, 2003, 423,181-85.
5. Bedalov, A.; Simon, J.A. Neuroscience: NAD to the rescue. Science, 2004, 305, 954-55.
6. Ziegler, M. New functions of a long-known molecule: Emerging roles of NAD in cellular signaling. Eur. J. Biochem., 2000, 267, 1550-64. (Pubitemid 30165506)
7. Pollak, N.; Dolle, C.; Ziegler, M. The power to reduce: Pyridine nucleotides-small molecules with a multitude of functions. Biochem. J., 2007, 402, 205-18. (Pubitemid 46383418)
8. Jayaram, H.N.; O'Connor, A.; Grant, M.R.; Yang,H.; Grieco, P.A.; Cooney, D.A. Biochemical consequences of resistance to a recently discovered IMP dehydrogenase inhibitor, benzamide riboside, in human myelogenous leukemia K562 cells. J. Exp. Ther. Oncol., 1996, 1, 278-85. (Pubitemid 126739046)
9. Boulton, S.; Kyle, S.; Durkacz, B.W. Low nicotinamide mononucleotide adenylyltransferase activity in a tiazofurin-resistant cell line: Effects on NAD metabolism and DNA repair. Br. J. Cancer, 1997, 76, 845-51. (Pubitemid 27401933)
10. Grifantini, M. Tiazofurine ICN Pharmaceuticals. Curr. Opin. Investig. Drugs., 2000; 1:257-62.
11. Cooney, D.A.; Jayaram, H.N.; Gebeyehu, G.; Betts, C.R.; Kelley, J.A.; Marquez, V.E.; Johns, D.G. The conversion of 2-beta-Dribofuranosylthiazole-4- carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. Biochem. Pharmacol., 1982, 31, 2133-6. (Pubitemid 12074439)
12. Zhang, R.G.; Zhang, F.; Hiesinger P.R.; Cao, Y.; Haueter, C.M.; Bellen, H.J. NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration. Nature, 2008, 452, 887-91. (Pubitemid 351550857)
13. Elisabetta, B.; Bogdan B.; Lucie J.; Rosalind B.; Jonathan G.; Derek T.; Richard R. R.; Michael P.C. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency In Vivo. J. Neurosci., 2010, 30, 13291-304.
14. Conforti, L.; Tarlton, A.; Till, G.A.; Weiqian, M.; Buckmaster, E.A.; Wagner, D.; Perry, H.V.; Coleman, M.P. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (Wlds) mouse. Proc. Natl. Acad. Sci. USA., 2000, 97,11377-82.
15. http://cubic.bioc.columbia.edu/cgi/var/nair/loctree/query. March, 2007.
16. Rong, G.; Menico, R.; Silvia, G. Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme. Cell. Mol. Life Sci., 2009, 66, 2805-18.
17. Zhang, X.; Kurnasov, O.V.; Karthikeyan, S.; Grishin, N.V.; Osterman, A.L.; Zhang, H. Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J. Biol. Chem., 2003, 278,13503-11. (Pubitemid 36800125)
18. Garavaglia, S.; D'Angelo, I.; Emanuelli, M.; Carnevali, F.; Pierella, F.; Magni, G.; Rizzi, M. Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis. J. Biol. Chem., 2002, 277, 8524-30. (Pubitemid 34968315)
19. Yalowitz, J.A.; Xiao, S.; Biju, M.P.; Antony, A.C.; Cummings, O.W.; Deeg, M.A.; Jayaram, H.N. Characterization of human brain nicotinamide 5'-mononucleotide adenylyltransferase-2 and expression in human pancreas. Biochem. J., 2004, 377,317-26. (Pubitemid 38142187)
20. Yahata,N.; Yusasa, S.; Araki T. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays wallerian degeneration. J. Neurosci., 2009, 29, 6276-84.
21. nd edition, London, 1992.
22. Arnold, S.T.; Jayaram, H.N.; Harper, G.R.; Litterest, C.L.; Malspeis, L.; DeSouza, J.J.; Staubus, A.E.; Ahluwalia, G.S.; Wilson, Y.A.; Cooney, D.A. The disposition and metabolism of tiazofurin in rodents, rabbits, and dogs. Drug Metab. Dispos., 1984, 12,165-73. (Pubitemid 14136534)
23. Gharehbaghi, K.; Paull, K. D; Kelley, J.A.; Barchi, J. J. Jr.; Marquez, V.E.; Cooney, D.A.; Monks, A.; Scudiero, D.; Krohn, K.; Jayaram, H.N. Cytotoxicity and characterization of an active metabolite of benzamide riboside, a novel inhibitor of IMP dehydrogenase. Int. J. Cancer, 1994, 56, 892-99. (Pubitemid 24102759)
24. Rick, A.F.; Ganapathi, R.R.; Pui, K.C. Nucleolar localization of nucleophosmin/B23 requires GTP. J. Biol. Chem. 1993, 268,5823-27.
25. Kazuyuki, H.; Toshie, H.; Hiroyuki, K. IMP Dehydrogenase inhibitors reduce intracellular tetrahydrobiopterin levels through reduction of intracellular GTP levels. Indications of the regulation of GTP cyclohydrolase I activity by restriction of GTP availability in the cells. J. Biol. Chem., 1992, 267, 20734-39.
26. Carney, D.N.; Ahluwalia, G.S.; Jayaram, H.N.; Cooney, D.A.; Johns, D.G. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells. The J. Clin. Inves., 1985, 175-82. (Pubitemid 15163983)
27. Jayaram, H.N. Biochemical mechanisms of resistance to tiazofurin. Adv. Enzyme Regul., 1985, 24, 67-89.
28. Franchetti, P.; Cappellacci, L.; Pasqualini, M.; Grifantini, M.; Lorenzi, T.; Raffaelli, N. Dinucleoside polyphosphate NAD analogs as potential NMN adenylyltransferase inhibitors:Synthesis and biological evaluation. Nucleosides Nucleotides Nucleic Acids, 2003, 22, 865-8. (Pubitemid 37139277)
29. O'Gara, M.J.; Lee, C.H.; Weinberg, G.A.; Nott, J.M.; Queener, S.F. IMP dehydrogenase from Pneumocystis carinii as a potential drug target. Antimicrob. Agents Chemother., 1997, 41, 40-8. (Pubitemid 26428130)
30. Oz, H.S.; Hughes, W.T. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone. J. Infect. Dis., 1997, 175, 901-4. (Pubitemid 27142965)
31. Berger, F.; Lau, C.; Ziegler, M. Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1. Proc. Natl. Acad. Sci. U S A., 2007, 104, 3765-70. (Pubitemid 47181528)
32. Dantzer, F.; Schreiber, V.; Niedergang, C.; Trucco, C.; Flatter, E.; de La, R.G. Involvement of poly(ADP-ribose) polymerase in base excision repair. Biochimie., 1999, 81, 69-75.
33. Chatterjee, S.; Berger, S.J.; Berger, N.A. Poly(ADP-ribose) polymerase: A guardian of the genome that facilitates DNA repair by protecting against DNA recombination. Mol. Cell Biochem., 1999, 193, 23-30. (Pubitemid 29176577)
34. D'Amours, D. ; Desnoyers, S.; D'Silva, I. ; Poirier, G.G. Poly(ADPribosyl) ation reactions in the regulation of nuclear functions. Biochem. J., 1999, 342, 249-68. (Pubitemid 29425344)
35. Dantzer, F.; Nasheuer, H.P.; Vonesch, J.L.; de Murcia, G.; Menissier-de, M.J. Functional association of poly(ADP-ribose) polymerase with DNA polymerase alpha-primase complex: A link between DNA strand break detection and DNA replication. Nucleic Acids Res.,1998, 26, 1891-8. (Pubitemid 28291721)
36. Griffin, R.J.; Curtin, N.J.; Newell, D.R.; Golding, B.T.; Durkacz, B.W.; Calvert, A.H. The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapy. Bio chimie., 1995, 77, 408-22.
37. Soldatenkov, V.A.; Smulson, M. Poly(ADP-ribose) polymerase in DNA damage-response pathway: Implications for radiation oncology. Int. J. Cancer, 2000, 90, 59-67 (Pubitemid 30253030)
38. Burkart, V.; Wang, Z.Q.; Radons, J.; Heller, B.; Herceg, Z.; Stingl, L.; Wagner, E.F.; Kolb, H. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat. Med., 1999, 5, 314-319. (Pubitemid 29124368)
39. Masutani, M.; Suzuki, H.; Kamada, N.; Watanabe, M.; Ueda, O.; Nozaki, T.; Jishage, Ki.; Watanabe, T.; Sugimoto, T.; Nakagama, H.; Ochiya, T.; Sugimura, T. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA., 1999, 96, 2301-04. (Pubitemid 29117909)
40. Budihardjo, I.I.; Walker, D.L.; Svingen, P.A.; Buckwalter, C.A.; Desnoyers, S.; Eckdahl, S.; Shah, G.M.; Poirier, G.G.; Reid, J.M.; Ames, M.M.;Kaufmann, S.H. 6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin. Clin.Cancer Res., 1998, 4, 117-30. (Pubitemid 28062885)
41. Gillingwater, T.H.; Wishart, T.M.; Chen, P.E.; Haley, J.E.; Robertson, K.; MacDonald, S.H-F.; Middleton, S.; Wawrowski, K.; Shipston, M.J.; Melmed, S.; Wyllie, D.J.A.; Skehel, P.A.; Coleman, M.P.; Ribchester, R.R. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. Hum. Mol. Genet., 2006, 15, 625-35. (Pubitemid 43205426)
42. Cai, A.L.; Zipfel, G.J.; Sheline, C.T. Zinc neurotoxicity is dependent on intracellular NAD levels and the sirtuin pathway. Eur. J. Neurosci., 2006, 24, 2169-76. (Pubitemid 44622338)
43. + consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med., 2009, 11, 28-42.
44. Revollo, J.R.; Grimm, A.A.; Imai, S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem., 2004, 279, 50754-63. (Pubitemid 40017813)
45. Mayer, P.R.; Huang, N.; Dewey, C.M.; Dries, D.R.; Zhang, H.; Yu, G. Expression, localization, and biochemical characterization of nicotinamide mononucleotide adenylyltransferase 2. J. Biol. Chem., 2010, 285, 40387-96.